CVE:NTB 12942 (NTB.V) (NTB) Stock Price, News & Analysis → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free NTB Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume31,049 shsAverage Volume315,395 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get 12942 (NTB.V) alerts: Email Address Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About 12942 (NTB.V)Neptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune’s distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company’s products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).Read More Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. NTB Stock News HeadlinesFebruary 9, 2024 | wsj.comBank of Butterfield Ltd.November 23, 2023 | seekingalpha.comNTB Dividend Yield GradeApril 23, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…October 19, 2023 | time.comNtb CouponsFebruary 19, 2023 | finance.yahoo.comNYSE U.S. 100 Index (^NY)See More Headlines Receive NTB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 12942 (NTB.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/15/2014Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorFinance Industry Regional Banks Sub-IndustryN/A Current SymbolCVE:NTB CUSIPN/A CIKN/A Webneptunekrilloil.com Phone+1-450-6872262FaxN/AEmployees1,134Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesJohn MoretzChairman of the BoardJames Stuart HamiltonPresident, Chief Executive Officer, DirectorMario ParadisChief Financial OfficerMichel TimperioSenior Vice President of Sales - Global SalesPierre Lemieux Ph.D.Chief Operating Officer of AcastiJean-Daniel BelangerCorporate Secretary and Director - Corporate AffairsHarlan W. Waksal M.D. (Age 61)Director Valier BoivinIndependent DirectorRonald DenisIndependent DirectorAdrian Taylor MontgomeryIndependent DirectorMore ExecutivesKey Competitors328 (MCA.V)CVE:MCA41246 (APO.V)CVE:APO543656 (OIL.V)CVE:OIL57012 (RPT.V)CVE:RPT86063 (HF.TO)TSE:HFView All Competitors NTB Stock Analysis - Frequently Asked Questions How were 12942 (NTB.V)'s earnings last quarter? 12942 (NTB.V) (CVE:NTB) released its earnings results on Tuesday, July, 15th. The biotechnology company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.02. The biotechnology company had revenue of $3.69 million for the quarter, compared to analyst estimates of $7.31 million. Is 12942 (NTB.V) a good dividend stock? 12942 (NTB.V) (CVE:NTB) pays an annual dividend of C$1.52 per share and currently has a dividend yield of 0.00%. What other stocks do shareholders of 12942 (NTB.V) own? Based on aggregate information from My MarketBeat watchlists, some companies that other 12942 (NTB.V) investors own include ACADIA Pharmaceuticals (ACAD), Adverum Biotechnologies (ADVM), Aimmune Therapeutics (AIMT), ANI Pharmaceuticals (ANIP), AxoGen (AXGN), Biohaven (BHVN), bluebird bio (BLUE), Blueprint Medicines (BPMC), Calithera Biosciences (CALA) and Codexis (CDXS). How do I buy shares of 12942 (NTB.V)? Shares of NTB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:NTB) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersIs Tesla going out of business?DTIGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 12942 (NTB.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
